Workforce Reskilling Is Becoming a Global Priority The world’s workforce is currently experiencing a huge shift in 2026. Digital technologies and automation have revolutionized the nature of work. The traditional educational systems are failing to cope with this change and hence, there is an enormous need for platforms that support reskilling and upskilling. This has […]
Author: evolve.venture capital
The AI Infrastructure Gold Rush: How Venture Capital Investing in Early Stage Startups is Reshaping Global Markets
The Trillion-Dollar Shift in Venture Capital Priorities The global venture capital market is currently undergoing its largest change since the dot-com bubble. As of March 2026, venture capital investing in early-stage startups has seen a dramatic pivot into artificial intelligence infrastructure, with unprecedented levels of capital being invested into compute, storage, and energy infrastructure that […]
The Rise of AI-Native Startups: How Venture Capital Firm is Reshaping Early-Stage Investment in 2026
The Dawn of Agentic AI in Venture Capital The world of venture capital is undergoing a paradigmatic shift as Agentic AI, or autonomous AI systems that enable independent decision-making, has been identified as the hottest trend in venture capital for the year 2026. As a leading venture capital firm in the industry, Evolve Venture Capital […]
Raise Capital for Startups as DePIN Becomes the Hottest Web3 Investment Trend in 2026
Web3 funding is back and roaring in 2026, and this time, the money is going into something far more practical than the hype cycles of years past. Investors aren’t throwing money at token plays anymore. They’re pouring it into blockchain-based systems that are building real-world infrastructure. And the fastest-growing segment of this new wave of […]
AI Drug Discovery Startups Reach Record Valuations
AI Drug Discovery Startups Achieve Record Valuations as Healthcare AI Attracts $585M in November 2025 Healthcare AI startups shattered funding records in November 2025, with companies developing AI-powered drug discovery platforms raising $585 million across multiple deals. This unprecedented investment surge reflects growing venture capital firm confidence that artificial intelligence is fundamentally transforming pharmaceutical development […]





